Recently, Titan Pharmaceutical Co., Ltd. (Guangdong) successfully participated in the 2024 CPHI China Exhibition, which was held grandly at the Shanghai New International Expo Centre from June 19 to June 21. This exhibition featured over 3,400 exhibitors and brands. Titan Pharmaceutical, as a high-quality supplier of APIs (Active Pharmaceutical Ingredients), took this opportunity to showcase its strength in the research, development, and production of cephalosporin APIs to the world.

Since its establishment in the pharmaceutical industry in 1995, Titan Pharmaceutical has been committed to the research, development, and production of cephalosporin APIs. With its outstanding technical strength and market insight, the company has successfully obtained the production approvals for cefuroxime sodium and cefuroxime axetil, making it a pioneer in this field in China. Moreover, Titan Pharmaceutical has also acquired the EU GMP and CEP certificates for these two products, signifying that its product quality is in line with international standards and has won widespread recognition from the pharmaceutical industry both domestically and internationally.

During the exhibition, Titan Pharmaceutical team actively engaged in communication with visiting customers, conducting in-depth discussions on product production, supply, and future planning. With the outstanding quality of its products such as cefuroxime sodium and cefuroxime axetil, as well as the EU GMP and CEP certifications, the company attracted the attention of many well-known domestic and foreign pharmaceutical enterprises.

This participation not only further consolidated cooperative relationship between Titan Pharmaceutical and its existing customers, but also provided valuable opportunities for the company to explore new markets and expand global business. Titan Pharmaceutical will continue to devote itself to the research, development, and production of high-quality APIs, contributing to the development of the global pharmaceutical industry.

Looking ahead, Titan Pharmaceutical will continue to actively participate in international exhibitions and work closely with global partners to promote the prosperity and development of the pharmaceutical industry.